Space

Update

Space

Want SpaceX exposure. RKLB consolidating at $78. ARKX is still a trap.


Quick Snapshot

Signal Reading
Overall 🟡 Watch - RKLB flat over 30D, consolidating after volatility
Key insight RKLB $78.57 = same as 30D ago. Defense contract win offset Neutron test failure. Net neutral.

Action Matrix

Action Stocks Why
🔍 WATCH RKLB RSI 43, consolidating, defense contract positive but Neutron risk
DON'T BUY ARKX RSI 33, misleading ETF - has NO SpaceX exposure

Legend

  • RSI = Oversold (<30) - potential buying opportunity
  • RSI = Overbought (>70) - FOMO warning, may pullback
  • 52wkHi = % from 52-week high (how far below peak)

Data (Validated 2026-02-05, RKLB data as of 02/03, ARKX as of 02/02)

Stock Price 7D 30D 3M 52wkHi RSI Status Action
RKLB $78.57 -0.5% +0.6% +28.0% -21.0% 43 🟡 Consolidating 🔍 Watch
ARKX $31.67 -1.0% +0.7% +2.0% -11.0% 33 🟡 Weakening ❌ Don't Buy

Note: RKLB data from 02/03, ARKX from 02/02. May have moved. Verify before acting.


News Summary

RKLB - Rocket Lab

Date Headline Sentiment
2026-02-02 Largest contract ever - 18 missile-defense satellites 🟢 Bullish
2026-01-29 Stock could explode in 2026 - 38% YTD gain 🟢 Bullish
2026-01-28 Congress killed Mars sample-return funding 🔴 Bearish
2026-01-27 Neutron test failure - stock dropped 20% 🔴 Bearish
2026-01-30 Analyst target $72.9 - mixed outlook 🟡 Neutral

Net sentiment: Mixed - big contract win offset by test failure. Stock went sideways as a result.

ARKX - ARK Space ETF

  • RSI dropped from 33 to 33 (weakening)
  • Still has NO SpaceX (that's in ARKVX venture fund)
  • Renamed to "ARK Space & Defense Innovation ETF"
  • ARKX position bought at $32.40 on 01/07 = now DOWN -2.3% ($31.67)

Analysis

RKLB - Rocket Lab

Thesis: Public rocket company. Real SpaceX competitor. Actually builds rockets.

Metric Value Change from 02/01
Price $78.57 Was $78.57 (unchanged)
RSI 43 Was 43 (same)
30D +0.6% Was +1% (similar)
  • Price literally unchanged from 02/01 report
  • Market digesting mixed signals: defense win vs Neutron failure
  • 18-satellite defense contract = huge revenue visibility
  • Neutron test failure = technical risk remains
  • RSI 43 = neutral territory, not overbought or oversold
  • Waiting for clearer direction before entry

Verdict: 🔍 Watch - need Neutron progress update before committing

ARKX - ARK Space ETF (AVOID)

Thesis: Space ETF... but has NO SpaceX.

Metric Value
Price $31.67
RSI 33 (weakening)
30D +0.7%
Entry (01/07) $32.40
P&L -2.3%
  • Position bought at $32.40 on 01/07 is now losing money
  • Still has NO SpaceX exposure (that's ARKVX venture fund)
  • Top holdings are Trimble, Kratos, Iridium
  • RSI weakening to 33, approaching oversold
  • This is NOT the space play we wanted

Verdict: ❌ Consider selling ARKX position at small loss vs holding a misleading ETF


The Gold

Key Discoveries

Discovery Implication
RKLB flat for 4 days Market in "wait and see" mode after mixed news
ARKX position losing money Bought at $32.40, now $31.67 = -2.3%
Defense contracts = revenue stability RKLB pivoting from pure launch to satellite manufacturing
Neutron still a question mark Need to track development progress closely

Mistakes

Mistake Lesson
Bought ARKX without checking holdings Always verify ETF composition
ARKX down -2.3% Small loss, but wrong thesis entirely

Open Questions

  • Is RKLB Neutron failure a one-time issue or systemic?
  • Should I sell ARKX at -2.3% loss?
  • Is $65-70 a good RKLB entry after pullback?
  • Will defense contracts offset commercial rocket challenges?

Next Actions

  • Decide: sell ARKX position (wrong thesis) or hold
  • Set RKLB alert at $65 for entry
  • Monitor Neutron rocket development progress
  • Track RKLB defense contract execution
  • Refresh space data (4 days stale for RKLB)

Commands

cd stonks

the desk's own tooling
the desk's own tooling
the desk's own tooling
the desk's own tooling
10 events

No direct external sources are attached to this read.